BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 17382249)

  • 41. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
    Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of pegfilgrastim in mobilization of hematopoietic stem cells.
    Kroschinsky F; Hölig K; Ehninger G
    Transfus Apher Sci; 2008 Jun; 38(3):237-44. PubMed ID: 18490197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
    Balducci E; Azzarello G; Valenti MT; Capuzzo GM; Pappagallo GL; Pilotti I; Ausoni S; Bari M; Rosetti F; Sartori D; Ciappa A; Porcellini A; Vinante O
    Stem Cells; 2003; 21(1):33-40. PubMed ID: 12529549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management strategies for poor peripheral blood stem cell mobilization.
    Moog R
    Transfus Apher Sci; 2008 Jun; 38(3):229-36. PubMed ID: 18485822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
    Kroschinsky F; Hölig K; Poppe-Thiede K; Zimmer K; Ordemann R; Blechschmidt M; Oelschlaegel U; Bornhauser M; Rall G; Rutt C; Ehninger G
    Haematologica; 2005 Dec; 90(12):1665-71. PubMed ID: 16330441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
    Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
    Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction.
    Paczkowska E; Larysz B; Rzeuski R; Karbicka A; Jałowiński R; Kornacewicz-Jach Z; Ratajczak MZ; Machaliński B
    Eur J Haematol; 2005 Dec; 75(6):461-7. PubMed ID: 16313257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia.
    Viola A; Falco C; D'Elia R; D'Amico MR; Vicari L; Tambaro FP; Correale P; Laudati D; Palmieri S; Ferrara F
    Eur J Haematol; 2007 Jan; 78(1):41-7. PubMed ID: 17042770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis.
    Steward CG; Blair A; Moppett J; Clarke E; Virgo P; Lankester A; Burger SR; Sauer MG; Flanagan AM; Pamphilon DH; Orchard PJ
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):115-21. PubMed ID: 15682072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enumeration of bone marrow 'homing' haemopoietic stem cells from G-CSF-mobilised normal donors and influence on engraftment following allogeneic transplantation.
    Spencer A; Jackson J; Baulch-Brown C
    Bone Marrow Transplant; 2001 Dec; 28(11):1019-22. PubMed ID: 11781610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
    Watt SM; Austin E; Armitage S
    Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.
    Antonenas V; Garvin F; Webb M; Sartor M; Bradstock KF; Gottlieb D
    Cytotherapy; 2006; 8(2):158-65. PubMed ID: 16698689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid, progenitor cell self-renewal kinetics.
    Marley SB; Lewis JL; Zheng B; Davidson RJ; Davis JG; McDonald C; Alenzi FQ; Goldman JM; Gordon MY
    Bone Marrow Transplant; 2001 Feb; 27(3):241-8. PubMed ID: 11277171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The frequency and proliferative potential of megakaryocytic colony-forming cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow, and their correlation with total CFC numbers: implications for the quantitation of Meg-CFC to predict platelet engraftment following cord blood transplantation.
    Drygalski A; Xu G; Constantinescu D; Kashiwakura I; Farley T; Dobrila L; Rubinstein P; Adamson JW
    Bone Marrow Transplant; 2000 May; 25(10):1029-34. PubMed ID: 10828861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics and immunophenotypic characterization of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation.
    Albo C; de la Fuente J; Ares C; Alonso C; Feteira E
    Haematologica; 2004 Jul; 89(7):845-51. PubMed ID: 15257937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000.
    Suh C; Kim S; Kim SH; Kim EK; Lee JL; Park KU; Park JS; Lee J; Kim MW; Chi HS; Park CJ; Kim SW
    Transfusion; 2004 Dec; 44(12):1762-8. PubMed ID: 15584992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.